Receptor That Allows HIV To Infect Kidney Cells Identified

Researchers have found that a receptor, Transmembrane TNF-alpha, that is involved in many inflammatory diseases may allow HIV to infect kidney cells.

Highlights

Upto now it was unclear how the kidney epithelial cells, which do not express the major HIV-1 CD4 receptor, become infected.
Researchers investigated the mechanism underlying the infection of HIV-1 of kidney cells cultured from the urine of children with HIV-1 associated nephropathy.
They identified transmembrane TNF-alpha, the precursor of soluble TNF alpha facilitates the low level productive infection of kidney cells, that do no express CD4 receptor.

Transmembrane TNF-alpha may allow HIV to infect kidney cells that not express the major HIV-1 CD4 receptor, according to new research.

HIV-1 associated nephropathy (HIVAN) is a kidney condition that can arise in HIV-positive patients of African ancestry who are not treated appropriately with antiretroviral therapy.

About AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV

‘Transmembrane TNF-alpha could be the cause of infection of other CD4-negative epithelial cells, including those within the cervix or placenta, thus facilitating the transmission of HIV-1 from mother to fetus.’

Despite many years of extensive research, it remains unclear how patients’ kidney epithelial cells, which do not express the major HIV-1 CD4 receptor, become infected.

A new study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) describes a new mechanism to explain how HIV-1 may infect these cells.

A team led by Patricio Ray, MD and Jinliang Li, PhD (Children’s National Health System and The George Washington University Medical School) set out to investigate the mechanisms underlying the infection by HIV-1 of kidney cells—specifically podocytes and renal tubular epithelial cells—cultured from the urine of children with HIV-1 associated nephropathy.

Ibalizumab Drug - First Monoclonal Antibody for Multi-Drug Resistant HIV Treatment
Ibalizumab is the first monoclonal antibody which is used for Multi-drug resistant HIV Treatment.

Various treatments and analyses revealed a key player: transmembrane TNF-alpha, the precursor of soluble TNF alpha that is involved in many inflammatory diseases.

“We found that transmembrane TNF-alpha facilitates the low level productive infection of podocytes cultured from HIV-positive children and renal tubular epithelial cells that do not express CD4, a finding that may have wider clinical implications in understanding how children develop HIV-1 associated nephropathy” said Dr. Ray.

HIV Continues to Reside in Tissues of Patients Who Were Treated
The spectrum of non-AIDS defining diseases such as cancers and cardiovascular disease are likely driven by the presence of active, untreated virus in tissues.

The novel mechanism may also help explain how other CD4-negative epithelial cells, including those within the cervix or placenta, may become infected, thus facilitating the transmission of HIV-1 from mother to fetus.

“More studies are needed to confirm this notion, however,” Dr. Ray noted.

Initial HIV Care at Home may Increase Use of ART
Offering optional home care initiation after HIV self testing could be linked to a significant increase in the number of adults initiating antiretroviral therapy compared to standard HIV care

Study co-authors include Jharna Das, PhD, Pingtao Tang, PhD, Zhe, Han, PhD, and Jyoti Jaiswal, PhD.

Source-Medindia